Syncom Formulations (India) Ltd: Smallcap Pharma Company Soars to All-Time High, Outperforms Sector and Sensex

Sep 10 2024 09:20 AM IST
share
Share Via
Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has been performing exceptionally well in the stock market. Its stock price reached an all-time high of Rs. 27.51 on September 10, 2024. According to MarketsMojo, the stock call for Syncom Formulations (India) is 'Buy', reflecting its strong performance and consecutive gains in the last 5 days. The company has also outperformed its sector and the benchmark index, showcasing its potential for growth in the pharmaceutical industry. Investors should conduct their own research before investing.

Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has been making waves in the stock market with its recent performance. On September 10, 2024, the company's stock price reached an all-time high of Rs. 27.51, which is a significant milestone for the company.

According to MarketsMOJO, a leading stock market analysis and research platform, the stock call for Syncom Formulations (India) is 'Buy'. This is a positive sign for investors and reflects the company's strong performance in the market.

In terms of price performance, Syncom Formulations (India) has outperformed its sector by 2.35% and has been on a consecutive gain for the last 5 days. In this period, the stock has risen by an impressive 37.76%. Additionally, the stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bullish trend.

In comparison to the Sensex, a benchmark index for the Indian stock market, Syncom Formulations (India) has shown a remarkable 1-year performance of 197.83%, while the Sensex has only grown by 22.67%. This further highlights the company's strong growth and potential in the pharmaceutical industry.

With its consistent growth and positive market sentiment, Syncom Formulations (India) is definitely a company to watch out for in the smallcap segment. As always, it is important for investors to do their own research and make informed decisions before investing in any stock.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Syncom Formul. falling/rising?
Dec 18 2025 01:02 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 19 2025 08:09 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 17 2025 08:10 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 16 2025 08:09 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 15 2025 08:10 AM IST
share
Share Via
Most Read